Charles River Laboratories International (CRL) Total Liabilities (2009 - 2025)

Charles River Laboratories International (CRL) has reported Total Liabilities for 17 consecutive years, with $3.9 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Liabilities fell 2.39% year-over-year to $3.9 billion; the TTM figure through Dec 2025 stood at $3.9 billion (down 2.39% YoY), while the FY2025 annual figure was $3.9 billion, down 2.39% from the prior year.
• Total Liabilities came in at $3.9 billion for Q4 2025 at Charles River Laboratories International, down from $4.1 billion in the prior quarter.
• The five-year high for Total Liabilities was $4.8 billion in Q2 2022, with the low at $3.6 billion in Q1 2021.
• Average Total Liabilities over 5 years is $4.3 billion, with a median of $4.4 billion recorded in 2021.
• Across the five-year window, Total Liabilities soared 341.59% in 2021 and declined 11.37% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $4.4 billion in 2021, then grew by 3.32% to $4.6 billion in 2022, then slipped by 0.94% to $4.5 billion in 2023, then dropped by 11.37% to $4.0 billion in 2024, then retreated by 2.39% to $3.9 billion in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $3.9 billion, $4.1 billion, and $4.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.